PAD - Prescribing Advisory Database
PLEASE NOTE : This is a development system.

For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.

You are here : Home > PAD Profile : Somatropin - Growth failure - children

PAD Profile : Somatropin - Growth failure - children

Keywords :
NICE, Shared care, Turner syndrome, SHOX, growth hormone deficiency, prader-willi syndrome, chronic renal insufficiency, born small for gestational age, short stature homeobox-containing gene
Brand Names Include :
Growth hormone, Genotropin, Norditropin FlexPro, Omnitrope, Saizen, Zomacton

Traffic Light Status

Status 1 of 1.

Status :
Amber
Formulations :
  • Intra-articular injection
Trust Alignment :
Primary Care
ASPH
RSFT
SASH
SABP
Links :
Comments :
No comments returned.
Documents :
Type
Document
Review Date

Guidelines

No guidelines returned.

Other Drugs

Other Indications

No indications returned.

Additional Documents

Type
Document
Review Date

Committee Recommendations

Date
Committee Name
Narrative
07 August 2024
Surrey Heartlands Integrated Care System Area Prescribing Committee (APC)

The Surrey Heartlands Integrated Care System Area Prescribing Committee (APC) has agreed the reviewed AMBER shared care document for Recombinant human growth hormone for children and young people.

Associated BNF Codes

06. Endocrine System
06.05.01. Hypothalamic & anterior pituitary hormone & antioestrogens
This site uses its own and third party cookies to function properly and to improve performance, to maintain the session and to personalise user experience, as well as to obtain anonymous statistics about the use of the website. Visit our Privacy and Cookie Policy for more information on our data collection practices. By clicking 'Accept' you agree to our use of cookies for the purposes listed.
Learn More